Perioperative risk of hip arthroplasty in patients with cirrhotic liver disease

Young-Wan Moon1, Yong-Sik Kim, Soon-Yong Kwon

  • 1Department of Orthopedic Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center, 50 Ilwon-dong, Gangnam-gu, Seoul, Korea.

Insights

Hip arthroplasty in liver cirrhosis patients is associated with perioperative complications, particularly in advanced disease. Vigilance is recommended, though mortality is low in less severe cirrhosis cases.

Area of Science:

  • Orthopedic Surgery
  • Hepatology
  • Anesthesiology

Background:

  • Liver cirrhosis significantly impacts patient health and surgical risk.
  • Hip arthroplasty is a common procedure for hip conditions.

Purpose of the Study:

  • To evaluate perioperative complications and mortality in liver cirrhosis patients undergoing hip arthroplasty.
  • To identify risk factors associated with adverse outcomes.

Main Methods:

  • Retrospective review of 30 liver cirrhosis patients who underwent hip arthroplasty.
  • Analysis of perioperative complications, mortality, and correlation with Child-Pugh score and creatinine levels.

Main Results:

  • 26.7% of patients experienced perioperative complications, with wound infection being most common (10%).
  • Mortality occurred in 6.7% of patients, exclusively in Child-Pugh class C.
  • Higher Child-Pugh scores and creatinine levels were significantly associated with increased complications or death.

Conclusions:

  • Surgeons must be vigilant for perioperative complications in cirrhotic patients undergoing hip arthroplasty.
  • Risk stratification using Child-Pugh score is crucial for managing these patients.
  • While complications exist, mortality is relatively low in less severe cirrhosis.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...